Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.5 USD | -2.93% | -2.32% | +44.01% |
Jun. 04 | Wedbush Adjusts Price Target on NovoCure to $24 From $21, Maintains Neutral Rating | MT |
Jun. 03 | Novocure Announces the Presentation of Clinical Data from the Phase 3 Metis Trial | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.01% | 2.31B | |
-24.88% | 7.32B | |
+7.04% | 6.66B | |
+15.10% | 5.5B | |
-17.77% | 4.88B | |
+14.96% | 4.1B | |
-20.83% | 3.89B | |
-25.03% | 2.83B | |
+1.73% | 2.07B | |
+9.75% | 1.97B |
- Stock Market
- Equities
- NVCR Stock
- News NovoCure Limited
- Top Midday Gainers